Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.
STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy
28 March 2023
KEY TAKEAWAYS
- Rapid optimization of guideline directed oral HF therapy post discharge an acute HF event under a close follow up with regular laboratory and clinical assessment is safe and reduces all cause mortality and hospital readmission.
- NT-proBNP is one of the safety parameters to not only inform the improvement of signs and symptoms of congestion but also the functioning of the heart in patients with AHF.
- STRONG-HF study now would provide us with an avenue to raise awareness on the importance of GDMT optimization post AHF discharge, through educational initiatives.
